THE UNIVERSITY OF MANITOBA Patent applications |
Patent application number | Title | Published |
20150303546 | DIELECTRIC STRAP WAVEGUIDES, ANTENNAS, AND MICROWAVE DEVICES - A new class of antennas and microwave components are introduced. In this approach a high-permittivity dielectric film is applied (i.e. printed) on a dielectric substrate, which may be grounded. By changing the shape of the high-permittivity film, different microwave devices (e.g. waveguides, filters, couplers, and antennas) are produced. By changing the size and permittivity of the high-permittivity film and dielectric substrate, these elements are designed at different frequencies for different applications. Highly-efficient microwave devices can result due to the absence of surface currents. | 10-22-2015 |
20130143750 | Phoshorylation of Estrogen Receptor Alpha - The present invention provides use and methods markers based on the phosphorylation state of certain amino acid residues of estrogen receptor α. | 06-06-2013 |
20130079418 | Phoshorylation of Estrogen Receptor Alpha Serine 282 as a Marker for Endocrine Therapies in Breast Cancer - The present invention provides diagnostic methods and markers based on the phosphorylation state of certain amino acid residues of estrogen receptor α. The invention relates to the phosphorylation of specific estrogen receptor alpha residues as a marker for susceptibility to chemotherapy. The invention specifically discloses the phosphorylation of serine 282 of the ER-alpha, as a diagnostic marker for breast cancer cells which are more responsive to hormone therapy than cells without the said phosphorylation. | 03-28-2013 |
20110050214 | SYSTEM AND METHOD FOR MEASURING MAGNETIC FIELD STRENGTH USING A MECHANICAL RESONATOR - Methods and apparatus for measuring magnetic field are provided. A resonator having a resonant frequency is that varies as a function of magnetic field is driven with a drive signal, and produces an output that is converted to electrical form. This output is then processed to isolate interference components due to the drive signal and to produce a sense signal. The sense signal is the processed to produce the drive signal. The sense signal is also processed to produce an output representative of the magnetic field. | 03-03-2011 |
20090027611 | Metal Nanoparticle and Use Thereof for Inducing Chirality in Liquid Crystal Phases - The invention provides a metal nanoparticle comprising a metal and a chiral and/or thiolate group bonded to the metal. The monolayer-protected metal nanoparticle may be used as a chiral dopant in a liquid crystal. Accordingly, the invention also provides a colloidal suspension or dispersion comprising a metal nanoparticle comprising a metal and a chiral and/or thiolate group bonded to the metal, and a liquid crystal. | 01-29-2009 |
20090018343 | Fluorous Oxazolidinone Chiral Auxiliary Compounds and Methods of Manufacture - The present invention relates generally to perfluoroalkyl chiral auxiliary compounds and methods of manufacture. These compounds have the functionality to effectively support the synthesis of chiral compounds in single reactions, high-throughput parallel reactions, or combinatorial reactions The invention relates to two oxazolidinone chiral auxiliaries (1) and (2): wherein R | 01-15-2009 |
20080318880 | Neoadjuvant treatment of Breast Cancer - Neoadjuvant treatment of inflammatory or T3 to T4 breast cancer is carried out by administering to such patients a number of cycles of chemotherapy treatment in which DPPE first is administered followed by a combination of anthracyclines and taxanes. | 12-25-2008 |
20080226653 | Inhibition of Platelet Aggregation - The present invention relates generally to the field of hyperglycemia-induced complications. More particularly, it concerns methods and compositions for the treatment and prevention of microvascular complications associated with diabetes. In one embodiment, the present invention provides a method of inhibiting hyperglycemia-induced platelet activation in a subject by administering to the subject an effective amount of a TRPC6 inhibitor. | 09-18-2008 |